Tonix Pharmaceuticals
TNXP
TNXP
23 hedge funds and large institutions have $11.1M invested in Tonix Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
57% less capital invested
Capital invested by funds: $25.7M → $11.1M (-$14.6M)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.05M | |
| 2 | +$1.37M | |
| 3 | +$712K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$250K |
| 5 |
Millennium Management
New York
|
+$222K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$1.15M | |
| 3 | -$375K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$315K |
| 5 |
Bank of New York Mellon
New York
|
-$305K |